Revisiting Telomere Shortening in Cancer
AbstractTelomeres, the protective structures of chromosome ends are gradually shortened by each cell division, eventually leading to senescence or apoptosis. Cancer cells maintain the telomere length for unlimited growth by telomerase reactivation or a recombination-based mechanism. Recent genome-wide analyses have unveiled genetic and epigenetic alterations of the telomere maintenance machinery in cancer. While telomerase inhibition reveals that longer telomeres are more advantageous for cell survival, cancer cells often have paradoxically shorter telomeres compared with those found in the normal tissues. In this review, we summarize the latest knowledge about telomere length alterations in cancer and revisit its rationality. Finally, we discuss the potential utility of telomere length as a prognostic biomarker. View Full-Text
Share & Cite This Article
Okamoto, K.; Seimiya, H. Revisiting Telomere Shortening in Cancer. Cells 2019, 8, 107.
Okamoto K, Seimiya H. Revisiting Telomere Shortening in Cancer. Cells. 2019; 8(2):107.Chicago/Turabian Style
Okamoto, Keiji; Seimiya, Hiroyuki. 2019. "Revisiting Telomere Shortening in Cancer." Cells 8, no. 2: 107.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.